Mara lafiya na farko da ke da asarar ji mai alaƙa da shekaru yana karɓar sabon magani

Sakin Kyauta | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

An gudanar da ACOU085 ga majiyyaci na farko tare da asarar ji mai alaƙa da shekaru (presbycusis) a cikin binciken asibiti na Phase 1b a Jamus. Binciken farko na marasa lafiya wanda ya dace da cikakkun ma'auni na ciki / cirewa don gwaji mai gudana ya kusan kammala. Baya ga ka'idar makasudin binciken, gwada aminci da haƙuri na ɗan takarar miyagun ƙwayoyi a cikin ɗan adam a karon farko, ana gudanar da gwaje-gwajen ji na zahiri da na zahiri don tallafawa binciken haɗin kai.

ACOU085 ƙananan kwayoyin halitta ne, ɗan takarar magani na otoprotective wanda ke daidaita ƙayyadaddun manufa ta kwayoyin da aka fi dacewa da ita a cikin sel masu ji na kunnen ciki, abin da ake kira ƙwayoyin gashi na waje (OHC). ACOU085 ana siffanta shi da wani nau'i na musamman na aiki biyu: kwayoyin suna haifar da babban haɓaka aikin ji kuma yana ba da adana dogon lokaci na OHCs masu ban sha'awa. A cikin Disamba 2021, Acousia Therapeutics ta sami damar CTA ta BfArM ta Jamus don fara gwajin gwaji na asibiti na farko-cikin-dan Adam Phase 1b na ACOU085.

"Wannan mataki na gaba na Acousia's otoprotective drugs ACOU085 cikin nazarin marasa lafiya da ke fama da presbycusis alama ce mai mahimmanci a kan hanyarmu ta yin asarar ji ta zama cutar da za a iya magancewa," in ji Dokta Tim Boelke, Babban Jami'in Gudanarwa kuma Babban Jami'in Lafiya na Kamfanin.

Hubert Löwenheim, Farfesa ya kara da cewa: "Ina matukar alfahari da cewa aikin kimiyyar da aka yi amfani da shi, yanzu yana shiga cikin matakin asibiti ne kawai bayan shekaru 6 bayan fara cikakken shirin ci gaban miyagun ƙwayoyi na de novo akan wani labari, ingantacciyar manufa ta miyagun ƙwayoyi," in ji Hubert Löwenheim, Farfesa kuma Shugaban Sashen Otolaryngology-Head & Neck Surgery na Jami'ar Tübingen da Acousia Therapeutics co-kafa.

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...